Document is current

Article History

Received: 15 May 2024

Accepted: 12 November 2024

First Online: 25 November 2024

Declarations

:

: Pilar A. Saiz has been a consultant to and/or has received honoraria or grants from Adamed, Alter Medica, Angelini Pharma, CIBERSAM, Ethypharm Digital Therapy, European Commission, Government of the Principality of Asturias, Instituto de Salud Carlos III, Johnson & Johnson, Lundbeck, Otsuka, Pfizer, Plan Nacional Sobre Drogas, Rovi, Servier and Viatris España. Luis Jiménez Treviño has been a consultant to and/or has received honoraria or grants from Adamed, Alter Medica, Angelini Pharma, Cassen-Recordati, CIBERSAM, Eli Lilly, European Commission, Government of the Principality of Asturias, Instituto de Salud Carlos III, Johnson & Johnson, Lundbeck, Otsuka, Pfizer, and Servier outside the submitted work. Jennifer Fernandez-Fernandez has been a consultant to and/or has received honoraria or grants from Otsuka. Iria Grande has received grants and served as a consultant, advisor, or CME speaker for the following identities: Adamed, Angelini, Casen Recordati, Esteve, Ferrer, Gedeon Richter, Janssen-Cilag, Lundbeck, Lundbeck-Otsuka, Luye, SEI Healthcare, and Viatris outside the submitted work. She also receives royalties from Oxford University Press, Elsevier, and Editorial Médica Panamericana.

: The current proposal complies with the national (code of ethics of the national board of medicine) and international (Declaration of Helsinki, Fortaleza, Brasil, Octubre 2013) guidelines, and with the national regulations: Ley 14/2007, 3rd of July of Investigación Biomédica, and Ley Orgánica 3/2018, 5th of December, regarding Protección de Datos Personales y Garantía de Derechos Digitales. Data protection will be assured following EU regulations (General Data Protection Regulation 2016/679 and the Council of 27 April 2016). Individuals who attempted suicide will be screed by a psychiatrist at the emergency ward. After discharge, the participant will be asked verbally, whether he/she consents to be called by a study team member to inform he/she about the study. If the patient consents, a study team member will contact the patient within the first 24 h to explain the study aims, and to arrange an appointment. Participants who agreed will be given the Patient Information Sheet and Informed Consent. Participation will be voluntarily, and participants will be allowed to abandon the study at any time. The same procedure will be conducted to recruit the youth sample. The adolescent’s consent will also be obtained through the provision of age-appropriate information. Adolescents will be included in the study only if consent from both (the adolescent and his/her legal representative) is obtained. The project was evaluated at the Ethical Committees of each one of the participating sites.